RILEXINE 75 CEPHALEXIN ANTIBIOTIC TABLETS FOR DOGS AND CATS

Country: Australia

Language: English

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Buy It Now

Patient Information leaflet (PIL)

19-06-2017

Summary of Product characteristics (SPC)

19-06-2017

Active ingredient:

CEPHALEXIN AS CEPHALEXIN MONOHYDRATE

Available from:

VIRBAC (AUSTRALIA) PTY LTD

INN (International Name):

cephalexin as monohydrate(75mg/Tb)

Pharmaceutical form:

ORAL TABLET

Composition:

CEPHALEXIN AS CEPHALEXIN MONOHYDRATE ANTIBIOTIC Active 75.0 mg/Tb

Units in package:

256 Tabs

Class:

VM - Veterinary Medicine

Therapeutic group:

Therapeutic area:

ANTIBIOTIC & RELATED

Therapeutic indications:

Product summary:

Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: CAT: [ANTIBIOTIC - ANTI-INFECTIVE, ENTEROBACTER SPP., ESCHERICHIA COLI (E. COLI), INFECTIONS OF SOFT CUTANEOUS TISSUE, INFECTIONS OF THE DIGESTIVE TRACT, INFECTIONS OF THE RESPIRATORY TRACT, INFECTIONS OF THE URINARY TRACTS, KLEBSIELLA SPP., OSTEOMYELITIS, PROTEUS SPP., SALMONELLA, SHIGELLA SPP., STAPHYLOCOCCUS AUREUS]; DOG: [ANTIBIOTIC - ANTI-INFECTIVE, ENTEROBACTER SPP., ESCHERICHIA COLI (E. COLI), INFECTIONS OF SOFT CUTANEOUS TISSUE, INFECTIONS OF THE DIGESTIVE TRACT, INFECTIONS OF THE RESPIRATORY TRACT, INFECTIONS OF THE URINARY TRACTS, KLEBSIELLA SPP., OSTEOMYELITIS, PROTEUS SPP., SALMONELLA, SHIGELLA SPP., STAPHYLOCOCCUS AUREUS]; Poison schedule: 4; Withholding period: ; Host/pest details: CAT: [ANTIBIOTIC - ANTI-INFECTIVE, ENTEROBACTER SPP., ESCHERICHIA COLI (E. COLI), INFECTIONS OF SOFT CUTANEOUS TISSUE, INFECTIONS OF THE DIGESTIVE TRACT, INFECTIONS OF THE RESPIRATORY TRACT, INFECTIONS OF THE URINARY TRACTS, KLEBSIELLA SPP., OSTEOMYELITIS, PROTEUS SPP., SALMONELLA, SHIGELLA SPP., STAPHYLOCOCCUS AUREUS]; DOG: [ANTIBIOTIC - ANTI-INFECTIVE, ENTEROBACTER SPP., ESCHERICHIA COLI (E. COLI), INFECTIONS OF SOFT CUTANEOUS TISSUE, INFECTIONS OF THE DIGESTIVE TRACT, INFECTIONS OF THE RESPIRATORY TRACT, INFECTIONS OF THE URINARY TRACTS, KLEBSIELLA SPP., OSTEOMYELITIS, PROTEUS SPP., SALMONELLA, SHIGELLA SPP., STAPHYLOCOCCUS AUREUS]; For the treatment of bacteria susceptible to cephalexin in dogs and cats. For the treatment of infections of soft cutaneous tissue, respiratory and digestive infections, urinary infections. Prevention and treatment of osteomyelitis.DO NOT use in animals that are hypersensitive to cephalosporins & other penicillins. Some dogs may exhibit nausea, vomiting & diarrhoea.

Authorization status:

Registered

Authorization date:

2023-07-01

Patient Information leaflet

10 November, 1999
Page 1 of 2 Sulidene 50 – Carton
_______________________________________________________________________________________________
INFOPEST VERIFIES THAT THIS LABEL IS CONSISTENT WITH
THE NRA APPROVED TEXT LABEL OF 30/7/98
________
PRESCRIPTION ANIMAL REMEDY (RED)
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
_RILEXINE_


 75
CEPHALEXIN ANTIBIOTIC TABLETS FOR DOGS
ACTIVE CONSTITUENT: 75mg CEPHALEXIN
(as MONOHYDRATE) per tablet
FOR THE TREATMENT OF BACTERIA SUSCEPTIBLE TO CEPHALEXIN

INFECTIONS OF SOFT CUTANEOUS TISSUE
RESPIRATORY AND DIGESTIVE INFECTIONS
URINARY INFECTIONS
PREVENTION AND TREATMENT OF OSTEOMYTELITIS
256 TABLETS
(32 FOIL PACKS OF 8 TABLETS WITH DISPENSING ENVELOPE)
DIRECTIONS FOR USE:
THIS PRODUCT IS CONTRAINDICATED IN ANIMALS THAT ARE HYPERSENSITIVE TO
CEPHALOSPORINS AND
OTHER PENICILLINS.
SIDE EFFECTS: Some dogs may exhibit nausea, vomiting and diarrhoea.
DOSAGE AND ADMINISTRATION:
CATS AND DOGS: 30mg/kg/day at 12 hourly intervals (i.e. 1 tablet per
5kg bodyweight morning
and night). In refractory cases, dose may be increased to
37.5mg/kg/day at 12 hourly intervals
(i.e. 1 tablet per 4kg bodyweight morning and night).
Treatment should be carried out for at least 3 days at discretion of
Veterinarian.
Is active against certain strains of Penicillinases producing
_Staphylococcus aureus. _Effective
against susceptible_ E.coli, Klebsiella, Proteus, Salmonella, Shigella
and Enterobacter._
VIRBAC AUSTRALIA PTY. LIMITED
15 Pritchard Place, Peakhurst NSW 2210
DISPOSAL:
Dispose of empty container by wrapping with paper and putting in
garbage.
STORAGE:
Store below 30
º
C (Room Temperature).

Registered Trade Mark of Virbac.
[B]:
CODE: P6454-1
EXP:
NRA: 40379 / 0798
[B]: EXP:
Space
Required
22mm x 22mm
10 November, 1999
Page 2 of 2 Rilexine 75 – Blister
_______________________________________________________________________________________________

Read the complete document

Summary of Product characteristics

VIRBAC (AUSTRALIA) PTY. LTD.
DOCUMENT NO:
RILEXINE CEPHALEXIN
TABLETS
REVISION C
MATERIAL SAFETY DATA SHEET
Product Name:
Rilexine Cephalexin Antibiotic Tablets for Dogs and Cats
PAGE: 1 OF 4
DATE OF ISSUE
17 SEPTEMBER,
2008
EMERGENCY: VIRBAC: 02 9772 9772 OR 1800 242 100 (BUSINESS HOURS ONLY)
POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800
764 766 IN NEW ZEALAND)
SECTION 1 - IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY
COMPANY:
VIRBAC (AUSTRALIA) PTY. LTD
ABN 77 003 268 871
ADDRESS
361 Horsley Rd, Milperra, NSW 2214, Australia
Locked Bag 6000, Milperra Business Centre, NSW 1891, Australia
TELEPHONE:
(02) 9772 9772 or 1800 242 100
FAX:
(02) 9772 9773
EMERGENCY PHONE
As above during business hours; answering machine after hours
SUBSTANCE:
Cephalexin is an antibiotic
TRADE NAME:
Rilexine Cephalexin Antibiotic Tablets for Dogs and Cats
APVMA CODE:
40379: Rilexine 75 Cephalexin Antibiotic Tablets For Dogs And Cats
40380: Rilexine 300 Cephalexin Antibiotic Tablets For Dogs And Cats
PRODUCT USE:
For the treatment in dogs and cats of bacterial infections susceptible
to Cephalexin.
CREATION DATE:
JUNE, 2002
REVISION DATE:
JANUARY, 2008
SECTION 2 - HAZARDS IDENTIFICATION
STATEMENT OF HAZARDOUS NATURE
This product is classified as:
Not classified as hazardous according to the criteria of ASCC
Australia.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
Not Hazardous - No criteria found.
SUSDP CLASSIFICATION:
S4
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good.
UN NUMBER:
None allocated
EMERGENCY OVERVIEW
PHYSICAL DESCRIPTION & COLOUR
: White to off-white tablets (some are scored).
ODOUR:
No data.
MAJOR HEALTH HAZARDS:
No major health hazards are known.
POTENTIAL HEALTH EFFECTS
INHALATION
SHORT TERM EXPOSURE:
This product may be irritating, but is unlikely to cause anything more
than mild transient
discomfort.
LONG TERM EXPOSURE:
No data for health effects associated with long term inhalation.
SKIN CON

Read the complete document